Neonc Technologies (NTHI) Stock Price, News & Analysis

Company Overview

Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

Key Stats

• Today's Range: $2.95 to $3.18
• 50-Day Range: $2.99 to $5.53
• 52-Week Range: $2.95 to $12.99
• Volume: 234,721 shs
• Average Volume: 110,950 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $16.00
• Consensus Rating: Moderate Buy

Neonc Technologies Stock Analysis - MarketRank™

Neonc Technologies scored higher than 75% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Neonc Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 4 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Neonc Technologies has a consensus price target of $16.00, representing about 435.1% upside from its current price of $2.99.

Amount of Analyst Coverage

Neonc Technologies has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: N/A
• Proj. Earnings Growth: N/A

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Neonc Technologies has a short interest ratio ("days to cover") of 2.51, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Neonc Technologies has recently increased by 10.79%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Neonc Technologies does not currently pay a dividend.

Dividend Growth

Neonc Technologies does not have a long track record of dividend growth.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.03

News Sentiment

Neonc Technologies has a news sentiment score of 0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Neonc Technologies this week, compared to 3 articles on an average week.

Search Interest

Only 1 people have searched for NTHI on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

3 insiders have purchased shares of Neonc Technologies in the last three months. Multiple insiders buying is a strong bullish signal.

Insider Buying vs. Insider Selling

In the past three months, Neonc Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $530,149.00 in company stock and sold $0.00 in company stock.

Percentage Held by Institutions

Neonc Technologies has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/10/2026
• Today: 10/03/2026
• Next Earnings (Estimated): 11/12/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:NTHI
• Previous Symbol: NASDAQ:NTHI
• CIK: 1979414
• Web: www.neonc.com
• Phone: 310-663-7831
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Neonc Technologies: $16.00
• High Price Target: $20.00
• Low Price Target: $13.00
• Potential Upside/Downside: +435.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $39.99 thousand
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A